OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Theranostics in Neuroendocrine Tumors	34
Hepatocellular Carcinoma Genetic Classification	34
Human Papillomavirus–Directed Therapeutics for Human Papillomavirus–Associated Oropharyngeal Cancer	31
Improving Equity in Cancer Care in the Face of a Public Health Emergency	23
Adoptive Cell Therapy for Advanced Solid Tumors	16
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	14
Beyond the COVID-19 Pandemic	14
Menopausal Hormone Therapy and Breast Cancer	13
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?	12
Circulating Biomarkers in Glioblastoma	11
Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer	11
Autoimmune Cytopenia in CLL	10
Minimal Residual Disease in Multiple Myeloma	10
Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma	10
New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer	9
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	9
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	9
Oncology Physician Workforce Diversity	8
The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma	8
Social Drivers of Cancer Risk and Outcomes Among African American Men	7
Hepatocellular Carcinoma—Southeast Asia Updates	7
Treatment of Locally Recurrent Rectal Cancer	7
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?	7
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	7
Updates in Classification of Myelodysplastic Syndrome	7

PET Imaging of Metabolism, Perfusion, and Hypoxia	7
Toxicities From Antibody-Drug Conjugates	7
Disparities in Gynecologic Cancers	7
Supportive Care for Patients With Myelodysplastic Syndromes	7
Radiopharmaceuticals for Cancer Diagnosis and Therapy	7
Mechanistic Effects of Estrogens on Breast Cancer	6
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
New Metabolomic Insights Into Cancer	6
Chimeric Antigen Receptor T-Cell Therapy	6
Neurosurgical Advances for Malignant Gliomas	6
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	6
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer	6
Ecosystemic Approach to Understanding Gut Microbiome–Mediated Prevention of Colorectal Cancer	6
Introduction	6
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	6
Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia	6
Microbiome and Diet in Colon Cancer Development and Treatment	6
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	6
Hormone Replacement Therapy After Breast Cancer	6
Natural Killer Cell Recognition and Control of Epithelial Cancers	6
Current State of Cell Therapies for Breast Cancer	5
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	5
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	5
PARP Inhibitors in Pancreatic Cancer	5
The Evolution of Research and Therapy With Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: New Directions for Old Drugs	5
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	5
Management of Chronic Lymphocytic Leukemia in Less-Resourced Countries	5
Clinical Evidence Generation During a Pandemic	5
An Overview of Organoid and 3-Dimensional Models in Multiple Myeloma	5
Targeting HRAS in Head and Neck Cancer	5
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	5
Role of the Microbiome in Immunotherapy of Melanoma	5
Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy	5
Telehealth in Cancer Care	4
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	4
Building a Bridge to Equity in Health and Health Care in Cancer Care	4
From Bench to Bedside	4
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	4
Circulating Tumor DNA in Human Papillomavirus–Mediated Oropharynx Cancer	4
How Far We’ve Come	4
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	4
Digital Health for Oncological Care	4
Health Care Policy and Disparities in Health	4
Myelodysplastic Syndromes/Neoplasms—Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments	4
Individualizing Therapy for Malignant Gliomas	4
Impact of Precision Medicine in Oncology	4